Publications by authors named "M Prcina"

Claim this Profile
M
Monoclonal antibodies targeting two immunodominant epitopes on the Spike protein neutralize emerging SARS-CoV-2 variants of concern.
Branislav Kovacech, Lubica Fialova, Peter Filipcik, Rostislav Skrabana, Monika Zilkova, Michal Prcina

EBioMedicine· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ADAMANT: a placebo-controlled randomized phase 2 study of AADvac1, an active immunotherapy against pathological tau in Alzheimer's disease.
Petr Novak, Branislav Kovacech, Stanislav Katina, Reinhold Schmidt, Philip Scheltens, Michal Prcina

Nat Aging· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Humanized tau antibodies promote tau uptake by human microglia without any increase of inflammation.
Monika Zilkova, Anna Nolle, Branislav Kovacech, Eva Kontsekova, Petronela Weisova, Michal Prcina

Acta Neuropathol Commun· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic antibody targeting microtubule-binding domain prevents neuronal internalization of extracellular tau via masking neuron surface proteoglycans.
Petronela Weisová, Ondrej Cehlár, Rostislav Škrabana, Monika Žilková, Peter Filipčík

Acta Neuropathol Commun· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FUNDAMANT: an interventional 72-week phase 1 follow-up study of AADvac1, an active immunotherapy against tau protein pathology in Alzheimer's disease.
Petr Novak, Reinhold Schmidt, Eva Kontsekova, Branislav Kovacech, Tomas Smolek, Michal Prcina

Alzheimers Res Ther· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis